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When I first used the expression "cardiomyopathy" in 1956 I did not realise that I had coined a term that would become widely applied. Experience, however, has confirmed its value in describing isolated noncoronary, non-hypertensive, and non-valvar myocardial disease, especially when used with an adjective if the aetiology or morphology is sufficiently clear. Some authorities prefer to restrict its use to disorders of the myocardium of unknown cause; this would exclude hypertrophic cardiomyopathy which in most patients is an inherited disorder. Although the division into hypertrophic and congestive cardiomyopathies has proved helpful, classification remains somewhat unsatisfactory despite many worthy attempts to clarify the position.
Unexplained and isolated myocardial hypertrophy was described in the nineteenth century by German pathologists and an obstructive element was recognised in their reference to "conus stenosis". Two patients with massive hypertrophy were reported in 1907 by Schminke who considered that hypertrophy led to further hypertrophy.2 Several papers were published in the 1930s and 1940s under various titles describing isolated myocardial hypertrophy, and Evans's paper on "familial cardiomegaly" in the British Heart Journal was particularly important.3 He described nine patients seen at the London Hospital and emphasised the diagnostic importance of a family history of similar disease, frequent arrhythmias, and a tendency to sudden death. Brock later added another facet to the story in suggesting the possibility that hypertrophic muscle was responsible for obstruction.4 He had observed and was impressed by apparent obstruction of the outflow tract by hypertrophic muscle after pulmonary stenosis had been relieved by valvotomy and he later described apparently important muscular obstruction in the left ventricle. Teare 
Pathology
The pathology of this condition has been extensively described and discussed during the past three decades. The distribution of hypertrophy may be-generalised or regional (commonly in the anterior basal part of the septum or rarely confined to the free wall). Although morphology correlates well with dynamic function and physical signs, gross appearances do not correlate closely with symptoms in this condition. There should be no dispute about facts, but pathologists like clinicians tend to disagree about their interpretation. I refer to the specificity, or otherwise, of the myocardial disarray that is found in almost all cases. It seems that some minor degree of disarray occurs in secondary hypertrophy and this sign is therefore not specific, but in hypertrophic cardiomyopathy there is very extensive disorganisation of large muscle bundles as well as disarray between fibres and small whorls of muscle; furthermore there is even disorganisation of fibrils within a single cell. Organ abnormality such as visceromegaly, congenital defects, and evidence of endocrinopathy, other than as an effect of heart failure or embolism, are conspicuously absent at necropsy. There have been, however, a few reports of a familial hypertrophic cardiomyopathy associated with a mitochondrial abnormality affecting skeletal muscle.
Treatment
Treatment is essentially unsatisfactory because so far the hypertrophic process has not been reversed, but symptoms and possibly the course of the disease may be modified favourably. The The ever increasing knowledge of disease continually reveals new problems and thus widens the scope of our ignorance. Hypertrophic cardiomyopathy is no exception, since the capacity of a highly specialised tissue such as myocardium to grow beyond its allotted size is as remarkable a biological phenomenon as the timely cessation of normal growth. When increased resistance to contraction is the stimulus for myocardial hypertrophy the result is mostly homoeostatic and comprehensible, but what of apparently purposeless and almost chaotic hypertrophy? We know that there is usually a genetic fault but we know nothing of its origin or of its translation into pathogenesis. It is not surprising therefore that we have not yet found a means of reversing this extraordinary disorder.
